Cathay Biotech Inc.
688065.SS · SHH
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | CN¥474,589 | CN¥366,524 | CN¥612,655 | CN¥646,685 |
| Dep. & Amort. | CN¥321,158 | CN¥285,715 | CN¥265,122 | CN¥168,535 |
| Deferred Tax | CN¥0 | -CN¥70,598 | -CN¥36,080 | -CN¥16,918 |
| Stock-Based Comp. | CN¥0 | CN¥0 | CN¥16,166 | CN¥6,236 |
| Change in WC | -CN¥26,524 | -CN¥233,104 | -CN¥73,881 | -CN¥212,144 |
| Other Non-Cash | CN¥51,706 | CN¥220,914 | CN¥19,691 | CN¥1,789 |
| Operating Cash Flow | CN¥820,929 | CN¥569,451 | CN¥803,674 | CN¥594,183 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -CN¥843,313 | -CN¥1,569,781 | -CN¥4,198,356 | -CN¥1,474,675 |
| Net Acquisitions | CN¥0 | CN¥0 | CN¥6,140 | CN¥1,850,000 |
| Inv. Purchases | CN¥0 | -CN¥101,044 | CN¥0 | -CN¥1,850,000 |
| Inv. Sales/Matur. | CN¥0 | CN¥0 | CN¥0 | CN¥28,421 |
| Other Inv. Act. | CN¥20,252 | CN¥112,015 | -CN¥6,000 | CN¥1,320,000 |
| Investing Cash Flow | -CN¥823,061 | -CN¥1,558,810 | -CN¥4,198,216 | -CN¥126,254 |
| Financing Activities | – | – | – | – |
| Debt Repay. | CN¥122,813 | CN¥647,254 | CN¥386,470 | CN¥743,080 |
| Stock Issued | CN¥0 | CN¥0 | CN¥94,670 | CN¥0 |
| Stock Repurch. | -CN¥28,934 | -CN¥31,525 | -CN¥94,670 | CN¥0 |
| Dividends Paid | -CN¥140,835 | -CN¥137,746 | -CN¥206,852 | -CN¥339,631 |
| Other Fin. Act. | CN¥196,447 | -CN¥773,103 | CN¥224,261 | CN¥2,577,715 |
| Financing Cash Flow | CN¥149,492 | -CN¥262,160 | CN¥403,878 | CN¥2,987,449 |
| Forex Effect | CN¥24,825 | CN¥40,221 | CN¥59,983 | -CN¥9,185 |
| Net Chg. in Cash | CN¥172,185 | -CN¥1,211,298 | -CN¥2,930,681 | CN¥3,446,193 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | CN¥5,013,780 | CN¥6,225,077 | CN¥9,155,758 | CN¥5,709,564 |
| End Cash | CN¥5,185,965 | CN¥5,013,780 | CN¥6,225,077 | CN¥9,155,758 |
| Free Cash Flow | -CN¥22,384 | -CN¥1,000,329 | -CN¥3,394,683 | -CN¥880,491 |